Is it really a matter of simple dualism? Corticotropin-releasing factor receptors in body and mental health

Frontiers in Endocrinology

Volumn 4, Issue MAR, 2013, Pages

  Janssen, Donny ^a   Kozicz, Tamás ^a,b  

^a RADBOUD UNIVERSITY   (Netherlands)

^b TULANE UNIVERSITY   (United States)

Author keywords

Anxiety; CRF; CRFR1; CRFR2; Depression; HPA axis; Stress; Urocortins

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; UROCORTIN; UROCORTIN I; UROCORTIN II; UROCORTIN III;

AGGRESSIVENESS; ANIMAL BEHAVIOR; ANXIETY; ARCUATE NUCLEUS; CHOROID PLEXUS; DEPRESSION; DOPAMINERGIC NERVE CELL; FORCED SWIM TEST; GENE INACTIVATION; HUMAN; HYPERCORTISOLISM; MEDIAL AMYGDALA; MEMORY; MENTAL HEALTH; NEUROTRANSMISSION; NONHUMAN; PHENOTYPE; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; STRIA TERMINALIS; SUPRAOPTIC NUCLEUS;

EID: 84880574652     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2013.00028     Document Type: Review

References (126)

1. Baigent, S. M., and Lowry, P. J. (2000). mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues. J. Mol. Endocrinol. 25, 43-52.
2. Bale, T. L., Contarino, A., Smith, G. W., Chan, R., Gold, L. H., Sawchenko, P. E., et al. (2000). Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat. Genet. 24, 410-414.
3. Bale, T. L., Lee, K. F., and Vale, W. W. (2002a). The role of corticotropin-releasing factor receptors in stress and anxiety. Integr. Comp. Biol. 42, 552-555.
4. Bale, T. L., Picetti, R., Contarino, A., Koob, G. F., Vale, W. W., and Lee, K. F. (2002b). Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J. Neurosci. 22, 193-199.
5. Bale, T. L., and Vale, W. W. (2003). Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses. J. Neurosci. 23, 5295-5301.
6. Bale, T. L., and Vale, W. W. (2004). CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 44, 525-557.
7. Baumann, B., Danos, P., Krell, D., Diekmann, S., Leschinger, A., Stauch, R., et al. (1999). Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study. J. Neuropsychiatry Clin. Neurosci. 11, 71-78.
8. Behan, D. P., Linton, E. A., and Lowry, P. J. (1989). Isolation of the human plasma corticotrophin-releasing factor-binding protein. J. Endocrinol. 122, 23-31.
9. Bittencourt, J. C., and Sawchenko, P. E. (2000). Do centrally administered neuropeptides access cognate receptors? An analysis in the central corticotropin-releasing factor system. J. Neurosci. 20, 1142-1156.
10. Bittencourt, J. C., Vaughan, J., Arias, C., Rissman, R. A., Vale, W. W., and Sawchenko, P. E. (1999). Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J. Comp. Neurol. 415, 285-312.
11. Boorse, G. C., Crespi, E. J., Dautzenberg, F. M., and Denver, R. J. (2005). Urocortins of the South African clawed frog, Xenopus laevis: conservation of structure and function in tetrapod evolution. Endocrinology 146, 4851-4860.
12. Breu, J., Touma, C., Holter, S. M., Knapman, A., Wurst, W., and Deussing, J. M. (2012). Urocortin 2 modulates aspects of social behaviour in mice. Behav. Brain Res. 233, 331-336.
13. Chalmers, D. T., Lovenberg, T. W., Grigoriadis, D. E., Behan, D. P., and De Souza, E. B. (1996). Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol. Sci. 17, 166-172.
14. Chatzaki, E., Murphy, B. J., Wang, L., Million, M., Ohning, G. V., Crowe, P. D., et al. (2004). Differential profile of CRF receptor distribution in the rat stomach and duodenum assessed by newly developed CRF receptor antibodies. J. Neurochem. 88, 1-11.
15. Chen, A., Zorrilla, E., Smith, S., Rousso, D., Levy, C., Vaughan, J., et al. (2006). Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior. J. Neurosci. 26, 5500-5510.
16. Contarino, A., Dellu, F., Koob, G. F., Smith, G. W., Lee, K. F., Vale, W., et al. (1999). Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1. Brain Res. 835, 1-9.
17. Cortright, D. N., Nicoletti, A., and Seasholtz, A. F. (1995). Molecular and biochemical characterization of the mouse brain corticotropin-releasing hormone-binding protein. Mol. Cell. Endocrinol. 111, 147-157.
18. Coste, S. C., Kesterson, R. A., Heldwein, K. A., Stevens, S. L., Heard, A. D., Hollis, J. H., et al. (2000). Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat. Genet. 24, 403-409.
19. Coste, S. C., Murray, S. E., and Stenzel-Poore, M. P. (2001). Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress. Peptides 22, 733-741.
20. Critchley, H. D., Melmed, R. N., Featherstone, E., Mathias, C. J., and Dolan, R. J. (2001). Brain activity during biofeedback relaxation: a functional neuroimaging investigation. Brain 124, 1003-1012
21. Dallman, M. F., Akana, S. F., Cascio, C. S., Darlington, D. N., Jacobson, L., and Levin, N. (1987). Regulation of ACTH secretion: variations on a theme of B. Recent Prog. Horm. Res. 43, 113-173.
22. Davis, M. (1992). The role of the amygdala in fear and anxiety. Annu. Rev. Neurosci. 15, 353-375.
23. De Bellis, M. D., Gold, P. W., Geracioti, T. D. Jr., Listwak, S. J., and Kling, M. A. (1993). Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. Am. J. Psychiatry 150, 656-657.
24. de Kloet, E. R., Joels, M., and Holsboer, F. (2005). Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6, 463-475.
25. De Michele, M., Touzani, O., Foster, A. C., Fieschi, C., Sette, G., and McCulloch, J. (2005). Corticotropin-releasing factor: effect on cerebral blood flow in physiologic and ischaemic conditions. Exp. Brain Res. 165, 375-382.
26. Deussing, J. M., Breu, J., Kuhne, C., Kallnik, M., Bunck, M., Glasl, L., et al. (2010). Urocortin 3 modulates social discrimination abilities via corticotropin-releasing hormone receptor type 2. J. Neurosci. 30, 9103-9116.
27. Dufau, M. L., Tinajero, J. C., and Fabbri, A. (1993). Corticotropin-releasing factor: an antireproductive hormone of the testis. FASEB J. 7, 299-307.
28. Elliott, E., Ezra-Nevo, G., Regev, L., Neufeld-Cohen, A., and Chen, A. (2010). Resilience to social stress coincides with functional DNA methylation of the Crf gene in adult mice. Nat. Neurosci. 13, 1351-1353.
29. Gammie, S. C., Hasen, N. S., Stevenson, S. A., Bale, T. L., and D'Anna, K. L. (2005). Elevated stress sensitivity in corticotropin-releasing factor receptor 2 deficient mice decreases maternal, but not intermale aggression. Behav. Brain Res. 160, 169-177.
30. Groenink, L., Dirks, A., Verdouw, P. M., Schipholt, M., Veening, J. G., van der Gugten, J., et al. (2002). HPA axis dysregulation in mice overexpressing corticotropin releasing hormone. Biol. Psychiatry 51, 875-881.
31. Heinrichs, S. C., Cole, B. J., Pich, E. M., Menzaghi, F., Koob, G. F., and Hauger, R. L. (1992). Endogenous corticotropin-releasing factor modulates feeding induced by neuropeptide Y or a tail-pinch stressor. Peptides 13, 879-884.
32. Heinrichs, S. C., Min, H., Tamraz, S., Carmouche, M., Boehme, S. A., and Vale, W. W. (1997). Anti-sexual and anxiogenic behavioral consequences of corticotropinreleasing factor overexpression are centrally mediated. Psychoneuroendocrinology 22, 215-224.
33. Heuser, I., Bissette, G., Dettling, M., Schweiger, U., Gotthardt, U., Schmider, J., et al. (1998). Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment. Depress. Anxiety 8, 71-79.
34. Holsboer, F. (1999). The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J. Psychiatr. Res. 33, 181-214.
35. Holsboer, F., and Ising, M. (2010). Stress hormone regulation: biological role and translation into therapy. Annu. Rev. Psychol. 61, 81-109, C1-C11.
36. Hsu, S. Y., and Hsueh, A. J. (2001). Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med. 7, 605-611.
37. Iino, K., Sasano, H., Oki, Y., Andoh, N., Shin, R. W., Kitamoto, T., et al. (1997). Urocortin expression in human pituitary gland and pituitary adenoma. J. Clin. Endocrinol. Metab. 82, 3842-3850.
38. Iino, K., Sasano, H., Oki, Y., Andoh, N., Shin, R. W., Kitamoto, T., et al. (1999). Urocortin expression in the human central nervous system. Clin. Endocrinol. (Oxf.) 50, 107-114.
39. Inoue, K., Valdez, G. R., Reyes, T. M., Reinhardt, L. E., Tabarin, A., Rivier, J., et al. (2003). Human urocortin II, a selective agonist for the type 2 corticotropinreleasing factor receptor, decreases feeding and drinking in the rat. J. Pharmacol. Exp. Ther. 305, 385-393.
40. Justice, N. J., Yuan, Z. F., Sawchenko, P. E., and Vale, W. (2008). Type 1 corticotropin-releasing factor receptor expression reported in BAC transgenic mice: implications for reconciling ligand-receptor mismatch in the central corticotropin-releasing factor system. J. Comp. Neurol. 511, 479-496.
41. Kang, H. J., Adams, D. H., Simen, A., Simen, B. B., Rajkowska, G., Stockmeier, C. A., et al. (2007). Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J. Neurosci. 27, 13329-13340.
42. Keck, M. E. (2006). Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety. Amino Acids 31, 241-250.
43. Keen-Rhinehart, E., Michopoulos, V., Toufexis, D. J., Martin, E. I., Nair, H., Ressler, K. J., et al. (2009). Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes. Mol. Psychiatry 14, 37-50.
44. Kehne, J. H., and Cain, C. K. (2010). Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal models. Pharmacol. Ther. 128, 460-487.
45. Kishimoto, T., Pearse, R. V. II, Lin, C. R., and Rosenfeld, M. G. (1995). A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 92, 1108-1112.
46. Kishimoto, T., Radulovic, J., Radulovic, M., Lin, C. R., Schrick, C., Hooshmand, F., et al. (2000). Deletion of crhr2 reveals an anxiolytic role for corticotropinreleasing hormone receptor-2. Nat. Genet. 24, 415-419.
47. Kita, H. (2007). Globus pallidus external segment. Prog. Brain Res. 160, 111-133.
48. Koob, G. F., and Heinrichs, S. C. (1999). A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res. 848, 141-152.
49. Korosi, A., Kozicz, T., Richter, J., Veening, J. G., Olivier, B., and Roubos, E. W. (2007). Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord. J. Comp. Neurol. 502, 973-989.
50. Korosi, A., Veening, J. G., Kozicz, T., Henckens, M., Dederen, J., Groenink, L., et al. (2006). Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain. Brain Res. 1072, 46-54.
51. Kostich, W. A., Chen, A., Sperle, K., and Largent, B. L. (1998). Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor. Mol. Endocrinol. 12, 1077-1085.
52. Kozicz, T. (2007). On the role of urocortin 1 in the non-preganglionic Edinger-Westphal nucleus in stress adaptation. Gen. Comp. Endocrinol. 153, 235-240.
53. Kozicz, T. (2009). quot;Neurobiology of corticotrophin-releasing factor system components in stress; from adaptation to maladaptation,quot; in Neuropeptides and Peptide Analogs, eds M. Kovacs and I. Merchenthaler (Kerala: Research Signpost), 59-90.
54. Kozicz, T., Arimura, A., Maderdrut, J. L., and Lazar, G. (2002). Distribution of urocortin-like immunoreactivity in the central nervous system of the frog Rana esculenta. J. Comp. Neurol. 453, 185-198.
55. Kozicz, T., Bittencourt, J. C., May, P. J., Reiner, A., Gamlin, P. D., Palkovits, M., et al. (2011a). The Edinger-Westphal nucleus: a historical, structural, and functional perspective on a dichotomous terminology. J. Comp. Neurol. 519, 1413-1434.
56. Kozicz, T., Sterrenburg, L., and Xu, L. (2011b). Does midbrain urocortin 1 matter? A 15-year journey from stress (mal)adaptation to energy metabolism. Stress 14, 376-383.
57. Kozicz, T., Tilburg-Ouwens, D., Faludi, G., Palkovits, M., and Roubos, E. (2008). Gender-related urocortin 1 and brain-derived neurotrophic factor expression in the adult human midbrain of suicide victims with major depression. Neuroscience 152, 1015-1023.
58. Kozicz, T., Yanaihara, H., and Arimura, A. (1998). Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J. Comp. Neurol. 391, 1- 10.
59. Kuhne, C., Puk, O., Graw, J., Hrabe de Angelis, M., Schutz, G., Wurst, W., et al. (2012). Visualizing corticotropin-releasing hormone receptor type 1 expression and neuronal connectivities in the mouse using a novel multifunctional allele. J. Comp. Neurol. 520, 3150-3180.
60. Lebow, M., Neufeld-Cohen, A., Kuperman, Y., Tsoory, M., Gil, S., and Chen, A. (2012). Susceptibility to PTSD-like behavior is mediated by corticotropin-releasing factor receptor type 2 levels in the bed nucleus of the stria terminalis. J. Neurosci. 32, 6906-6916.
61. Lewis, K., Li, C., Perrin, M. H., Blount, A., Kunitake, K., Donaldson, C., et al. (2001). Identification of urocortin III, an additional member of the corticotropinreleasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U.S.A. 98, 7570-7575.
62. Li, C., Vaughan, J., Sawchenko, P. E., and Vale, W. W. (2002). Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. J. Neurosci. 22, 991-1001.
63. Lovenberg, T. W., Chalmers, D. T., Liu, C., and De Souza, E. B. (1995a). CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136, 4139-4142.
64. Lovenberg, T. W., Liaw, C. W., Grigoriadis, D. E., Clevenger, W., Chalmers, D. T., De Souza, E. B., et al. (1995b). Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. U.S.A. 92, 836-840.
65. Lowry, P. J., Koerber, S. C., Woods, R. J., Baigent, S., Sutton, S., Behan, D. P., et al. (1996). Nature of ligand affinity and dimerization of corticotrophin-releasing factor-binding protein may be detected by circular dichroism. J. Mol. Endocrinol. 16, 39-44.
66. Lukkes, J. L., Staub, D. R., Dietrich, A., Truitt, W., Neufeld-Cohen, A., Chen, A., et al. (2011). Topographical distribution of corticotropin-releasing factor type 2 receptor-like immunoreactivity in the rat dorsal raphe nucleus: co-localization with tryptophan hydroxylase. Neuroscience 183, 47-63.
67. Maillot, C., Million, M., Wei, J. Y., Gauthier, A., and Tache, Y. (2000). Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats. Gastroenterology 119, 1569-1579.
68. McEwen, B. S., Eiland, L., Hunter, R. G., and Miller, M. M. (2012). Stress and anxiety: structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology 62, 3-12.
69. Merali, Z., Du, L., Hrdina, P., Palkovits, M., Faludi, G., Poulter, M. O., et al. (2004). Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J. Neurosci. 24, 1478-1485.
70. Merchenthaler, I., Vigh, S., Petrusz, P., and Schally, A. V. (1982). Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain. Am. J. Anat. 165, 385-396.
71. Morin, S. M., Ling, N., Liu, X. J., Kahl, S. D., and Gehlert, D. R. (1999). Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuroscience 92, 281-291.
72. Muglia, L., Jacobson, L., Dikkes, P., and Majzoub, J. A. (1995). Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 373, 427-432.
73. Muller, M. B., Preil, J., Renner, U., Zimmermann, S., Kresse, A. E., Stalla, G. K., et al. (2001). Expression of CRHR1 and CRHR2 in mouse pituitary and adrenal gland: implications for HPA system regulation. Endocrinology 142, 4150-4153.
74. Muller, M. B., Zimmermann, S., Sillaber, I., Hagemeyer, T. P., Deussing, J. M., Timpl, P., et al. (2003). Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat. Neurosci. 6, 1100-1107.
75. Nappi, R. E., and Rivest, S. (1995). Stress-induced genetic expression of a selective corticotropin-releasing factor-receptor subtype within the rat ovaries: an effect dependent on the ovulatory cycle. Biol. Reprod. 53, 1417-1428.
76. Nemeroff, C. B., Widerlov, E., Bissette, G., Walleus, H., Karlsson, I., Eklund, K., et al. (1984). Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226, 1342-1344.
77. Nemeroff, C. B., Owens, M. J., Bissette, G., Andorn, A. C., and Stanley, M. (1988). Postmortem study with brains of suicide victims revealing reduced CRH-binding sites in the frontal cortex as result of chronic CRH overexpression. Arch. Gen. Psychiatry 45, 577-579.
78. Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., and Monteggia, L. M. (2002). Neurobiology of depression. Neuron 34, 13-25.
79. Neufeld-Cohen, A., Evans, A. K., Getselter, D., Spyroglou, A., Hill, A., Gil, S., et al. (2010a). Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits. Mol. Psychiatry 15, 426-441, 339.
80. Neufeld-Cohen, A., Tsoory, M. M., Evans, A. K., Getselter, D., Gil, S., Lowry, C. A., et al. (2010b). A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery. Proc. Natl. Acad. Sci. U.S.A. 107, 19020-19025.
81. Neufeld-Cohen, A., Kelly, P. A., Paul, E. D., Carter, R. N., Skinner, E., Olverman, H. J., et al. (2012). Chronic activation of corticotropin-releasing factor type 2 receptors reveals a key role for 5-HT1A receptor responsiveness in mediating behavioral and serotonergic responses to stressful challenge. Biol. Psychiatry 72, 437- 447.
82. Okosi, A., Brar, B. K., Chan, M., D'Souza, L., Smith, E., Stephanou, A., et al. (1998). Expression and protective effects of urocortin in cardiac myocytes. Neuropeptides 32, 167-171.
83. Orth, D. N., and Mount, C. D. (1987). Specific high-affinity binding protein for human corticotropin-releasing hormone in normal human plasma. Biochem. Biophys. Res. Commun. 143, 411-417.
84. Palchaudhuri, M. R., Hauger, R. L., Wille, S., Fuchs, E., and Dautzenberg, F. M. (1999). Isolation and pharmacological characterization of two functional splice variants of corticotropin-releasing factor type 2 receptor from Tupaia belangeri. J. Neuroendocrinol. 11, 419-428.
85. Parkes, D. G., Vaughan, J., Rivier, J., Vale, W., and May, C. N. (1997). Cardiac inotropic actions of urocortin in conscious sheep. Am. J. Physiol. 272, H2115-H222.
86. Perrin, M. H., and Vale, W. W. (1999). Corticotropin releasing factor receptors and their ligand family. Ann. N. Y. Acad. Sci. 885, 312-328.
87. Potter, E., Behan, D. P., Fischer, W. H., Linton, E. A., Lowry, P. J., and Vale, W. W. (1991). Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature 349, 423-426.
88. Potter, E., Behan, D. P., Linton, E. A., Lowry, P. J., Sawchenko, P. E., and Vale, W. W. (1992). The central distribution of a corticotropin-releasing factor (CRF)- binding protein predicts multiple sites and modes of interaction with CRF. Proc. Natl. Acad. Sci. U.S.A. 89, 4192-4196.
89. Preil, J., Muller, M. B., Gesing, A., Reul, J. M., Sillaber, I., van Gaalen, M. M., et al. (2001). Regulation of the hypothalamic-pituitary-adrenocortical system in mice deficient for CRH receptors 1 and 2. Endocrinology 142, 4946-4955.
90. Refojo, D., Echenique, C., Muller, M. B., Reul, J. M., Deussing, J. M., Wurst, W., et al. (2005). Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas. Proc. Natl. Acad. Sci. U.S.A. 102, 6183-6188.
91. Refojo, D., Schweizer, M., Kuehne, C., Ehrenberg, S., Thoeringer, C., Vogl, A. M., et al. (2011). Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science 333, 1903-1907.
92. Regev, L., Neufeld-Cohen, A., Tsoory, M., Kuperman, Y., Getselter, D., Gil, S., et al. (2011). Prolonged and site-specific over-expression of corticotropin-releasing factor reveals differential roles for extended amygdala nuclei in emotional regulation. Mol. Psychiatry 16, 714-728.
93. Regev, L., Tsoory, M., Gil, S., and Chen, A. (2012). Site-specific genetic manipulation of amygdala corticotropin-releasing factor reveals its imperative role in mediating behavioral response to challenge. Biol. Psychiatry 71, 317-326.
94. Reul, J. M., and Holsboer, F. (2002). Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr. Opin. Pharmacol. 2, 23-33.
95. Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., et al. (2001). Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. U.S.A. 98, 2843-2848.
96. Ryabinin, A. E., Tsivkovskaia, N. O., and Ryabinin, S. A. (2005). Urocortin 1-containing neurons in the human Edinger-Westphal nucleus. Neuroscience 134, 1317- 1323.
97. Sanacora, G., Zarate, C. A., Krystal, J. H., and Manji, H. K. (2008). Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat. Rev. Drug Discov. 7, 426-437.
98. Selye, H. (1936). A syndrome produced by diverse nocuous agents. Nature 138, 32.
99. Selye, H. (1951). The general adaptation syndrome and the diseases of adaptation. Am. J. Med. 10, 549-555.
100. Slominski, A., Ermak, G., Hwang, J., Chakraborty, A., Mazurkiewicz, J. E., and Mihm, M. (1995). Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin. FEBS Lett. 374, 113-116.
101. Smith, G. W., Aubry, J. M., Dellu, F., Contarino, A., Bilezikjian, L. M., Gold, L. H., et al. (1998). Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20, 1093-1102.
102. Spina, M., Merlo-Pich, E., Chan, R. K., Basso, A. M., Rivier, J., Vale, W., et al. (1996). Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273, 1561-1564.
103. Stenzel-Poore, M. P., Cameron, V. A., Vaughan, J., Sawchenko, P. E., and Vale, W. (1992). Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology 130, 3378-3386.
104. Stenzel-Poore, M. P., Heinrichs, S. C., Rivest, S., Koob, G. F., and Vale, W. W. (1994). Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 14, 2579-2584.
105. Swanson, L. W., Sawchenko, P. E., Rivier, J., and Vale, W. W. (1983). Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36, 165-186.
106. Sztainberg, Y., Kuperman, Y., Justice, N., and Chen, A. (2011). An anxiolytic role for CRF receptor type 1 in the globus pallidus. J. Neurosci. 31, 17416-17424.
107. Sztainberg, Y., Kuperman, Y., Tsoory, M., Lebow, M., and Chen, A. (2010). The anxiolytic effect of environmental enrichment is mediated via amygdalar CRF receptor type 1. Mol. Psychiatry 15, 905-917.
108. Takahashi, K., Totsune, K., Sone, M., Murakami, O., Satoh, F., Arihara, Z., et al. (1998). Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain. Peptides 19, 643-647.
109. Tanaka, M., and Telegdy, G. (2008). Antidepressant-like effects of the CRF family peptides, urocortin 1, urocortin 2 and urocortin 3 in a modified forced swimming test in mice. Brain Res. Bull. 75, 509-512.
110. Terui, K., Higashiyama, A., Horiba, N., Furukawa, K. I., Motomura, S., and Suda, T. (2001). Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart. J. Endocrinol. 169, 177-183.
111. Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M., Stalla, G. K., et al. (1998). Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat. Genet. 19, 162-166.
112. Todorovic, C., Jahn, O., Tezval, H., Hippel, C., and Spiess, J. (2005). The role of CRF receptors in anxiety and depression: implications of the novel CRF1 agonist cortagine. Neurosci. Biobehav. Rev. 29, 1323-1333.
113. Turnbull, A. V., and Rivier, C. (1997). Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides. Proc. Soc. Exp. Biol. Med. 215, 1-10.
114. Vale, W., Spiess, J., Rivier, C., and Rivier, J. (1981). Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and betaendorphin. Science 213, 1394-1397.
115. Vale, W., Vaughan, J., and Perrin, M. H. (1997). Corticotropin-releasing factor (CRF) family of ligands and their receptors. Endocrinologist 7, 3S-9S.
116. van Gaalen, M. M., Stenzel-Poore, M. P., Holsboer, F., and Steckler, T. (2002). Effects of transgenic overproduction of CRH on anxiety-like behaviour. Eur. J. Neurosci. 15, 2007-2015.
117. Van Pett, K., Viau, V., Bittencourt, J. C., Chan, R. K., Li, H. Y., Arias, C., et al. (2000). Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 428, 191-212.
118. Vaughan, J., Donaldson, C., Bittencourt, J., Perrin, M. H., Lewis, K., Sutton, S., et al. (1995). Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378, 287-292.
119. Venihaki, M., and Majzoub, J. A. (1999). Animal models of CRH deficiency. Front. Neuroendocrinol. 20, 122-145.
120. Vetter, D. E., Li, C., Zhao, L., Contarino, A., Liberman, M. C., Smith, G. W., et al. (2002). Urocortin-deficient mice show hearing impairment and increased anxietylike behavior. Nat. Genet. 31, 363-369.
121. Wanat, M. J., Hopf, F. W., Stuber, G. D., Phillips, P. E., and Bonci, A. (2008). Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih. J. Physiol. (Lond.) 586, 2157-2170.
122. Wang, X., Su, H., Copenhagen, L. D., Vaishnav, S., Pieri, F., Shope, C. D., et al. (2002). Urocortin-deficient mice display normal stress-induced anxiety behavior and autonomic control but an impaired acoustic startle response. Mol. Cell. Biol. 22, 6605-6610.
123. Weninger, S. C., Dunn, A. J., Muglia, L. J., Dikkes, P., Miczek, K. A., Swiergiel, A. H., et al. (1999). Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proc. Natl. Acad. Sci. U.S.A. 96, 8283-8288.
124. Weninger, S. C., Peters, L. L., and Majzoub, J. A. (2000). Urocortin expression in the Edinger-Westphal nucleus is up-regulated by stress and corticotropin-releasing hormone deficiency. Endocrinology 141, 256-263.
125. Wong, M. L., Dong, C., Maestre-Mesa, J., and Licinio, J. (2008). Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol. Psychiatry 13, 800-812.
126. Zalutskaya, A. A., Arai, M., Bounoutas, G. S., and Abou-Samra, A. B. (2007). Impaired adaptation to repeated restraint and decreased response to cold in urocortin 1 knockout mice. Am. J. Physiol. Endocrinol. Metab. 293, E259-E263.